Q1 sales were significantly ahead of expectations fuelled by increasing demand for FilmArray’s respiratory tests amid the ongoing COVID-19 pandemic. While respiratory and recently-developed COVID-19 tests should bolster growth going forward, the number of patients seeking consultations for other diseases is falling substantially. This could result in a slowdown in the routine laboratory business and, in turn, bioMerieux’s immunoassays and microbiology segments (the impact was visi
